Presence of hypochlorite-modified proteins in human atherosclerotic lesions

Journal of Clinical Investigation

Volumn 97, Issue 6, 1996, Pages 1535-1544

  Hazell, Linda J ^a   Arnold, Leslie ^b   Flowers, Dimity ^b   Waeg, Georg ^c   Malle, Ernst ^c   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

antioxidants; atherogenesis; low density lipoprotein; myeloperoxidase; oxidation

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; APOLIPOPROTEIN B100; COPPER ION; HYPOCHLORITE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MONOCLONAL ANTIBODY; MYELOPEROXIDASE;

ADULT; ANTIGEN BINDING; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID OXIDATION; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0029932445     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118576     Document Type: Article

References (36)

1. Steinberg, D., S Parthasarathy, T.E. Carew. J.C. Khoo, and J.L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:915-924.
2. Steinbrecher, U P., H. Zhang, and M. Lougheed. 1990. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. & Med. 9:155-168.
3. Ross, R. 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
4. Haberland, M.E., D. Fong, and L. Cheng. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe Heritable Hyperlipidemic rabbits. Science (Wash. DC). 241:215-218.
5. Boyd, H.C., A.M. Gown, G. Wolfbauer, and A. Chait. 1989. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atheroselerotic lesions from a Watanabe Heritable Hyperlipidemic rabbit. Am J. Pathol. 135:815-825.
6. Rosenfeld, M.E., W. Palinski. S. Ylä-Herttuala, S. Butler, and J.L. Witztum. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:336-349.
7. Rosenfeld, M.E., J.C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J.L. Witztum. 1991 Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:90-99.
8. Jürgens, G., Q. Chen, H. Esterbauer, S. Mair, G. Ledinski, and H.P. Dinges. 1993. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler. Thromb. 13:1689-1699.
9. Salmon, S., C Maziere, L. Theron, I Beucler, M. Ayrault-Jarrier, S Goldstein, and J. Polonovski. 1987 Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo. Biochim Biophys. Acta. 920:215-220.
10. Palinski, W., M.E. Rosenfeld, S. Ylä-Herttuala, G.C Gurtner, S.S. Socher, S.W. Butler, S. Parthasarathy, T.E. Carew, D. Steinberg, and J.L. Witztum 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci USA. 86:1372-1376.
11. Salonen, J.T., S Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssonen, W. Palinski, and J.L. Witztum. 1992 Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339: 883-887.
12. Hazell, L.J., and R. Stocker. 1993. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:165-172.
13. Hazell, L.J., J J. M. van den Berg, and R. Stocker. 1994. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:297-304.
14. O'Connell, A.M., S.P. Gieseg, and K.K. Stanley. 1994. Hypochlorite oxidation causes cross-linking of Lp(a) Biochim. Biophys. Acta 1225.180-186.
15. Gerrity, R.G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol 103:181-190.
16. Daugherty, A., J.L. Dunn, D.L. Rateri, and J.W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin. Invest. 94:437-444.
17. Malle, E., L. Hazell, R. Stocker, W. Sattler, H. Esterbauer, and G. Waeg. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. 1995. Arterioscler. Thromb. Vasc. Biol. 15:982-989
18. Sattler, W., D, Mohr, and R. Stocker. 1994. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 233:469-489.
19. Smith, P K , R.J. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E K. Fujimoto, N.M. Goeke, B.J. Olson, and D C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
20. Morton, R.E , and T.A Evans. 1992. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content Anal. Biochem. 204:332-334.
21. Stary, H.C., A B. Chandler, S. Glagov, J.R. Guyton, W Insull, M.E Rosenfeld, S.A. Schaffer, C.J Schwartz, W.D. Wagner, and R.W. Wissler. 1994. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association Arterioscler. Thromb. 14:840-856.
22. Bancroft, J.D., and A. Stevens. 1982 Theory and practice of histological techniques Churchill Livingstone, London 116-117.
23. Daugherty, A., B.S. Zweifel, B E. Sobel, and G. Schonfeld. 1988. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe Heritable Hyperlipidemic rabbits. Arteriosclerosis 8:768-777.
24. Ylä-Herttuala, S., W Palinski, M.E Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum. and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J. Clin. Invest. 84:1086-1095.
25. Hoff, H.F., and J. O'Neil. 1991 Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb 11 1209-1222.
26. Yla-Herttuala, S , W. Palinski, S W, Butler, S. Picard, D. Steinberg, and J L Witztum 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40.
27. Savenkova, M.L., D.M. Mueller, and J.W. Heinecke. 1994. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:20394-20400.
28. Kikugawa, K., T. Kato, and A. Hayasaka. 1991. Formation of dityrosine and other fluorescent amino acids by reaction of amino acids with lipid hydroperoxides. Lipids. 26:922-929.
29. Palinski, W., S. Ylä-Herttuala, M.E. Rosenfeld, S.W. Butler, S.A. Socher, S. Parthasarathy, L.K. Curtiss, and J.L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:325-335.
30. Winterbourn, C.C., J.J.M. van den Berg, E. Roitman, and F.A. Kuypers. 1992. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 296:547-555.
31. Heinecke, J.W., W. Li, D.M. Mueller, A. Bohrer, and J. Turk. 1994. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: Potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry. 33:10127-10136.
32. Stroncek, D., G.M. Vercellotti, P.W. Huh, and H.S. Jacob 1986. Neutrophil oxidants inactivate alpha-1-protease inhibitor and promote PMN-mediated detachment of cultured endothelium. Arteriosclerosis 6:332-340.
33. Adams, D.O., and T.A. Hamilton. 1992. Macrophages as destructive cells in host defense. In Inflammation: Basic principles and clinical correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman. Raven Press, New York. 637-662.
34. Vissers, M.C.M., and C.C. Winterbourn. 1991. Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl. Arch. Biochem. Biophys. 285:53-59.
35. Frei, B., R. Stocker, and B.N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl. Acad. Sci. USA. 85:9748-9752.
36. Hu, M.L , S. Louie, C.E. Cross, P. Motchnik, and B. Halliwell. 1993. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 121:257-262.